Safety of Ramelteon in Subjects With Mild to Moderate Chronic Obstructive Pulmonary Disease
NCT00672802
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
26
Enrollment
INDUSTRY
Sponsor class
Conditions
Chronic Obstructive Pulmonary Disease
COPD
Interventions
DRUG:
Ramelteon and Placebo
Sponsor
Takeda